Page de couverture de Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes

Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes

Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression.

Read the article:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv

And the personal view:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Ce que les auditeurs disent de Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.